Zobrazeno 1 - 10
of 765
pro vyhledávání: '"Thyroid Transcription Factor 1"'
Autor:
Yuting Wu, Jingxu Li, Li Ding, Jianbin Huang, Mingwang Chen, Xiaomei Li, Xiang Qin, Lisheng Huang, Zhao Chen, Yikai Xu, Chenggong Yan
Publikováno v:
Cancer Imaging, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background To explore the value of dual-energy computed tomography (DECT) in differentiating pathological subtypes and the expression of immunohistochemical markers Ki-67 and thyroid transcription factor 1 (TTF-1) in patients with non-small
Externí odkaz:
https://doaj.org/article/cc0b643209944bf19914ef16d76d8db5
Autor:
Christy D Ramya, K Rama
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 18, Iss 09, Pp 17-21 (2024)
Introduction: Metastasis to the brain as a first presentation is very rare and challenging. Metastatic tumours are ten times more common in the brain than primary intracranial neoplasms. Brain metastasis to brain causes severe neurological morbidity
Externí odkaz:
https://doaj.org/article/5dcbf18746e84850b7f50df2717fb04c
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 17, Iss 10, Pp 20-24 (2023)
Introduction: Lung cancer is a highly aggressive malignancy that causes significant morbidity and mortality. The incidence of lung cancer has been increasing in the past few decades. Cytology aids in the initial evaluation and diagnosis of patient
Externí odkaz:
https://doaj.org/article/caa1f00451aa4180b7d3ce8c13c84cdc
Autor:
Xiaosheng Ding, Weiwei Shi, Bingxuan Han, Hanxiao Chen, Jia Li, Juan An, Lili Zhou, Weiran Xu, Hui Shi, Xixi Zheng, Yichun Hua, Xiaoyan Li
Publikováno v:
Thoracic Cancer, Vol 14, Iss 29, Pp 2934-2940 (2023)
Abstract Background The absence of thyroid transcription factor 1 (TTF‐1) is associated with a lower frequency of epidermal growth factor receptor (EGFR) mutations in lung adenocarcinoma (LUAD). The aim of this study was to assess the impact of TTF
Externí odkaz:
https://doaj.org/article/7b3421b022c743a0b916d79b59f98a63
Publikováno v:
Xin yixue, Vol 54, Iss 3, Pp 191-196 (2023)
Objective To investigate the expression levels of thyroid transcription factor-1 （TTF-1） and CyclinD1 in ovarian cancer and analyze their relationship with lymphangiogenesis. Methods The ovarian cancer tissue samples were collected from 60 patien
Externí odkaz:
https://doaj.org/article/f36dfc111174466eb749c9aec3eafbe5
Autor:
Yuto Terashima, MD, Masaru Matsumoto, MD, PhD, Hiroki Iida, MD, Sae Takashima, MD, Aya Fukuizumi, MD, PhD, Susumu Takeuchi, MD, PhD, Akihiko Miyanaga, MD, PhD, Yasuhiro Terasaki, MD, PhD, Kazuo Kasahara, MD, PhD, Masahiro Seike, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 11, Pp 100578- (2023)
Introduction: Pervious studies reported the association of TTF-1 expression with the efficacy of platinum-doublet chemotherapy in combination with immune checkpoint inhibitors in advanced nonsquamous NSCLC. Nevertheless, the predictive value of exten
Externí odkaz:
https://doaj.org/article/a8d24f9941d1407ebf190954c5f35839
Publikováno v:
Molecules, Vol 29, Iss 2, p 552 (2024)
Thyroid transcription factor 1 (TTF1) is an important cancer-related biomarker for clinical diagnosis, especially for carcinomas of lung and thyroid origin. Herein, a novel label-free electrochemical immunosensor was prepared for TTF1 detection based
Externí odkaz:
https://doaj.org/article/49276d37cd8c43b4ad6f6204e6c8a2d9
Autor:
Yuki Katayama, MD, Tadaaki Yamada, MD, PhD, Kenji Morimoto, MD, PhD, Hiroyuki Fujii, MD, Satomi Morita, MD, Keiko Tanimura, MD, PhD, Takayuki Takeda, MD, PhD, Asuka Okada, MD, PhD, Shinsuke Shiotsu, MD, PhD, Yusuke Chihara, MD, PhD, Osamu Hiranuma, MD, Takahiro Yamada, MD, PhD, Takahiro Ota, MD, PhD, Taishi Harada, MD, Isao Hasegawa, MD, PhD, Akihiro Yoshimura, MD, PhD, Masahiro Iwasaku, MD, PhD, Shinsaku Tokuda, MD, PhD, Young Hak Kim, MD, PhD, Koichi Takayama, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 4, Pp 100494- (2023)
Introduction: Lung adenocarcinoma with negative TTF-1 expression is believed to be a poor prognostic factor for certain systemic treatments. Nevertheless, the impact of TTF-1 expression on combined chemoimmunotherapy remains unclear. We aimed to inve
Externí odkaz:
https://doaj.org/article/f5a29b79c158468da31bfa4f00a93ada
Publikováno v:
Journal of Pathology and Translational Medicine, Vol 56, Iss 1, Pp 53-56 (2022)
SMARCA4/BRG1-deficient lung adenocarcinoma (SD-LUAD) is being recognized as a distinct subtype based on subtle differences in its clinical, morphological, and immunophenotypic attributes compared to other non–small cell lung carcinomas. We present
Externí odkaz:
https://doaj.org/article/42ee0f92bae0492ca1e6151b23c66fdc
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.